Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
CCO
|
Scott Wells
Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 194,175 Added 10.12% |
-
|
Apr 01
2022 |
|
CCO
|
Jason Dilger
Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 16,465 Reduced 8.0% |
$57,298
$3.48 p/Share
|
Apr 01
2022 |
|
CCO
|
Jason Dilger
Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 32,362 Added 13.58% |
-
|
Apr 01
2022 |
|
CCO
|
Christopher William Eccleshare |
SELL
Payment of exercise price or tax liability
|
Direct | 257,795 Reduced 15.37% |
$897,127
$3.48 p/Share
|
Apr 01
2022 |
|
CCO
|
Christopher William Eccleshare |
BUY
Exercise of conversion of derivative security
|
Direct | 242,718 Added 12.64% |
-
|
Apr 01
2022 |
|
CCO
|
Lynn Feldman |
SELL
Payment of exercise price or tax liability
|
Direct | 114,739 Reduced 17.45% |
$399,292
$3.48 p/Share
|
Apr 01
2022 |
|
CCO
|
Lynn Feldman |
BUY
Exercise of conversion of derivative security
|
Direct | 113,268 Added 14.7% |
-
|
Apr 01
2022 |
|
BMRC
|
Tani Girton
EXECUTIVE VICE PRESIDENT |
SELL
Sale (or disposition) back to the issuer
|
Direct | 1,223 Reduced 2.45% |
-
|
Apr 01
2022 |
|
BMRC
|
Robert Gotelli
EXECUTIVE VICE PRESIDENT |
SELL
Sale (or disposition) back to the issuer
|
Direct | 778 Reduced 3.49% |
-
|
Apr 01
2022 |
|
BMRC
|
Russell A Colombo |
SELL
Sale (or disposition) back to the issuer
|
Direct | 3,093 Reduced 20.98% |
-
|
Apr 01
2022 |
|
BMRC
|
Timothy D Myers
PRESIDENT & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 168 Reduced 0.6% |
$5,774
$34.37 p/Share
|
Apr 01
2022 |
|
BMRC
|
Timothy D Myers
PRESIDENT & CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct | 1,112 Reduced 3.8% |
-
|
Apr 01
2022 |
|
SRDX
|
Gary R Maharaj
President & CEO |
SELL
Open market or private sale
|
Direct | 100 Reduced 0.06% |
$4,555
$45.55 p/Share
|
Apr 01
2022 |
|
SRDX
|
Gary R Maharaj
President & CEO |
SELL
Open market or private sale
|
Direct | 3,900 Reduced 2.45% |
$175,383
$44.97 p/Share
|
Apr 01
2022 |
|
COOK
|
James H Hardy Jr
President of Apption Labs |
SELL
Payment of exercise price or tax liability
|
Direct | 5,526 Reduced 2.23% |
$41,003
$7.42 p/Share
|
Apr 01
2022 |
|
CRGY
|
Erich Bobinsky
Director |
BUY
Grant, award, or other acquisition
|
Direct | 9,131 Added 50.0% |
-
|
Apr 01
2022 |
|
CRGY
|
Claire S Farley
Director |
BUY
Grant, award, or other acquisition
|
Direct | 9,131 Added 50.0% |
-
|
Apr 01
2022 |
|
CRGY
|
Robert G Gwin
Director |
BUY
Grant, award, or other acquisition
|
Direct | 9,131 Added 50.0% |
-
|
Apr 01
2022 |
|
CRGY
|
Bevin Brown
Director |
BUY
Grant, award, or other acquisition
|
Direct | 9,131 Added 50.0% |
-
|
Apr 01
2022 |
|
CRGY
|
Karen Jo Simon
Director |
BUY
Grant, award, or other acquisition
|
Direct | 9,131 Added 38.55% |
-
|
Apr 01
2022 |
|
CRGY
|
Bo Shi
Officer |
BUY
Grant, award, or other acquisition
|
Direct | 7,305 Added 50.0% |
-
|
Apr 01
2022 |
|
CRGY
|
Ellis L Mccain
Director |
BUY
Grant, award, or other acquisition
|
Direct | 9,131 Added 17.79% |
-
|
Apr 01
2022 |
|
CRGY
|
Pt Independence Energy Holdings LLC |
BUY
Grant, award, or other acquisition
|
Indirect | 18,262 Added 50.0% |
-
|
Apr 01
2022 |
|
NRDS
|
Kenneth Thomas Mcbride
Director |
BUY
Grant, award, or other acquisition
|
Direct | 26,714 Added 50.0% |
-
|
Apr 01
2022 |
|
PLCE
|
Jared Shure
CAO, GEN COUNSEL & SECRETARY |
BUY
Grant, award, or other acquisition
|
Direct | 472 Added 25.6% |
-
|
Apr 01
2022 |
|
PLCE
|
Leah Swan
CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 8,860 Added 9.4% |
-
|
Apr 01
2022 |
|
PLCE
|
Robert F Helm
CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 10,156 Added 20.08% |
-
|
Apr 01
2022 |
|
PLCE
|
Claudia Lima Guinehut
BRAND PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct | 5,907 Added 16.98% |
-
|
Apr 01
2022 |
|
HY
|
Vincent Poor
Director |
BUY
Grant, award, or other acquisition
|
Direct | 849 Added 7.46% |
-
|
Apr 01
2022 |
|
HY
|
James Bemowski
Director |
BUY
Grant, award, or other acquisition
|
Direct | 849 Added 8.83% |
-
|
Apr 01
2022 |
|
HY
|
Di Ahn Taplin |
BUY
Grant, award, or other acquisition
|
Indirect | 849 Added 0.22% |
-
|
Apr 01
2022 |
|
HY
|
Carolyn Corvi
Director |
BUY
Grant, award, or other acquisition
|
Direct | 849 Added 4.96% |
-
|
Apr 01
2022 |
|
HY
|
Edward T Eliopoulos
Director |
BUY
Grant, award, or other acquisition
|
Direct | 849 Added 15.78% |
-
|
Apr 01
2022 |
|
HY
|
John P Jumper
Director |
BUY
Grant, award, or other acquisition
|
Direct | 849 Added 4.87% |
-
|
Apr 01
2022 |
|
HY
|
Eugene Wong
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 1,345 Added 2.03% |
-
|
Apr 01
2022 |
|
HY
|
Dennis W Labarre
Director |
BUY
Grant, award, or other acquisition
|
Direct | 849 Added 3.2% |
-
|
Apr 01
2022 |
|
HY
|
Claiborne R Rankin
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 849 Added 0.32% |
-
|
Apr 01
2022 |
|
HY
|
Chloe O Rankin |
BUY
Grant, award, or other acquisition
|
Indirect | 849 Added 0.32% |
-
|
Apr 01
2022 |
|
HY
|
John C Butler Jr
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 849 Added 1.63% |
-
|
Apr 01
2022 |
|
HY
|
Helen Rankin Butler |
BUY
Grant, award, or other acquisition
|
Indirect | 849 Added 1.63% |
-
|
Apr 01
2022 |
|
HY
|
David B Williams
Director |
BUY
Grant, award, or other acquisition
|
Direct | 849 Added 6.71% |
-
|
Apr 01
2022 |
|
HY
|
Clara R Williams |
BUY
Grant, award, or other acquisition
|
Indirect | 849 Added 6.71% |
-
|
Apr 01
2022 |
|
ATLCP
|
Deal W Hudson
Director |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 3.06% |
$153,720
$51.24 p/Share
|
Apr 01
2022 |
|
ACET
|
Francesco Galimi
SVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 7,621 Reduced 11.28% |
$160,041
$21.0 p/Share
|
Apr 01
2022 |
|
ACET
|
Francesco Galimi
SVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 7,621 Added 10.14% |
$45,497
$5.97 p/Share
|
Apr 01
2022 |
|
CLW
|
Michael S Gadd
SVP, GC, Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct | 4,011 Reduced 4.73% |
$112,428
$28.03 p/Share
|
Apr 01
2022 |
|
CLW
|
Steve M Bowden
Sr. V.P. |
SELL
Open market or private sale
|
Direct | 4,589 Reduced 11.42% |
$129,823
$28.29 p/Share
|
Apr 01
2022 |
|
CLW
|
Steve M Bowden
Sr. V.P. |
SELL
Payment of exercise price or tax liability
|
Direct | 10,955 Reduced 21.42% |
$307,069
$28.03 p/Share
|
Apr 01
2022 |
|
CLW
|
Arsen S. Kitch
President, CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 2,554 Reduced 2.13% |
$71,589
$28.03 p/Share
|
Apr 01
2022 |
|
CLW
|
Kari G. Moyes
SVP, HR |
SELL
Payment of exercise price or tax liability
|
Direct | 9,492 Reduced 16.64% |
$266,061
$28.03 p/Share
|
Apr 01
2022 |